BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34553659)

  • 1. Success stories of AI in drug discovery - where do things stand?
    Mak KK; Balijepalli MK; Pichika MR
    Expert Opin Drug Discov; 2022 Jan; 17(1):79-92. PubMed ID: 34553659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
    Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
    Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of artificial intelligence to enhance phenotypic drug discovery.
    Malandraki-Miller S; Riley PR
    Drug Discov Today; 2021 Apr; 26(4):887-901. PubMed ID: 33484947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential applications of artificial intelligence in drug discovery and development.
    Farghali H; Kutinová Canová N; Arora M
    Physiol Res; 2021 Dec; 70(Suppl4):S715-S722. PubMed ID: 35199553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generative artificial intelligence empowers digital twins in drug discovery and clinical trials.
    Bordukova M; Makarov N; Rodriguez-Esteban R; Schmich F; Menden MP
    Expert Opin Drug Discov; 2024; 19(1):33-42. PubMed ID: 37887266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [No Abstract]   [Full Text] [Related]  

  • 7. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.
    Cova T; Vitorino C; Ferreira M; Nunes S; Rondon-Villarreal P; Pais A
    Methods Mol Biol; 2022; 2390():321-347. PubMed ID: 34731476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
    Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C
    Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenges of generalizability in artificial intelligence for ADME/Tox endpoint and activity prediction.
    Huang DZ; Baber JC; Bahmanyar SS
    Expert Opin Drug Discov; 2021 Sep; 16(9):1045-1056. PubMed ID: 33739897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical assessment of AI in drug discovery.
    Walters WP; Barzilay R
    Expert Opin Drug Discov; 2021 Sep; 16(9):937-947. PubMed ID: 33870801
    [No Abstract]   [Full Text] [Related]  

  • 11. A Study on the Application and Use of Artificial Intelligence to Support Drug Development.
    Lamberti MJ; Wilkinson M; Donzanti BA; Wohlhieter GE; Parikh S; Wilkins RG; Getz K
    Clin Ther; 2019 Aug; 41(8):1414-1426. PubMed ID: 31248680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
    Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
    Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Intelligence (AI) in Drugs and Pharmaceuticals.
    Sahu A; Mishra J; Kushwaha N
    Comb Chem High Throughput Screen; 2022; 25(11):1818-1837. PubMed ID: 34875986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Artificial Intelligence in Drug Discovery.
    Chopra H; Baig AA; Gautam RK; Kamal MA
    Curr Pharm Des; 2022; 28(33):2690-2703. PubMed ID: 35676841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing preclinical drug discovery with artificial intelligence.
    Vijayan RSK; Kihlberg J; Cross JB; Poongavanam V
    Drug Discov Today; 2022 Apr; 27(4):967-984. PubMed ID: 34838731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How can artificial intelligence be used for peptidomics?
    Perpetuo L; Klein J; Ferreira R; Guedes S; Amado F; Leite-Moreira A; Silva AMS; Thongboonkerd V; Vitorino R
    Expert Rev Proteomics; 2021 Jul; 18(7):527-556. PubMed ID: 34343059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing health care via artificial intelligence: From concept to clinic.
    Sandeep Ganesh G; Kolusu AS; Prasad K; Samudrala PK; Nemmani KVS
    Eur J Pharmacol; 2022 Nov; 934():175320. PubMed ID: 36220360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review.
    Kolluri S; Lin J; Liu R; Zhang Y; Zhang W
    AAPS J; 2022 Jan; 24(1):19. PubMed ID: 34984579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unleashing the power of generative AI in drug discovery.
    Gangwal A; Lavecchia A
    Drug Discov Today; 2024 Jun; 29(6):103992. PubMed ID: 38663579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.